Drug Testing Locations - South Chicago Heights, IL

Drug Testing in South Chicago Heights, IL

South Chicago Heights, Illinois Statistics

In 2021, Cook County, home to South Chicago Heights, reported over 1,200 opioid-related overdose deaths.

The Illinois Department of Public Health recorded 24,947 opioid-related emergency department visits in Cook County in 2020.

In 2019, Cook County ranked among the top five Illinois counties for heroin-related treatment admissions.

A 2020 report indicated South Chicago Heights, Cook County, experienced a 35% increase in narcotics arrests compared to the previous year.

Research shows that in 2022, approximately 8% of Cook County high school students reported using illicit drugs.

Cook County had a 14 percent increase in fentanyl-related deaths from 2020 to 2021 as per local health departments.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in South Chicago Heights, IL & Drug Testing Policies

Employers in South Chicago Heights, Cook County are keenly aware of the impacts of drug abuse and incorporate comprehensive drug testing policies to maintain a safe workplace. Many local companies use pre-employment drug screenings to deter substance misuse. To guarantee a drug-free environment, standard protocols such as random testing are employed. These measures are essential in sectors demanding high safety standards.

Additionally, employers work closely with the U.S. Department of Labor and local agencies to implement drug education and support programs. Providing rehabilitation support and creating awareness about substance misuse in the workspace promotes recovery and reduces stigma. South Chicago Heights businesses are committed to balancing employee well-being and productivity, fostering a healthy and responsible community.

Government Efforts with Drug Problems in South Chicago Heights, IL

The government of South Chicago Heights, Cook County, has established multiple strategies to address drug abuse. Key efforts include collaborations with local organizations and the implementation of educational programs aimed at increasing awareness in schools. Furthermore, initiatives like the Illinois State Opioid Response Grant Program provide local treatment and recovery services to individuals in need. These community-based interventions focus on minimizing the impact of drug-related issues.

State efforts also play a crucial role in addressing the crisis. The Illinois Department of Human Services has developed the Substance Use Prevention and Recovery Division, coordinating efforts to reduce drug abuse across Cook County. With targeted financial support and initiatives, the division works with local agencies to ensure access to pivotal resources. Additionally, federal grants have facilitated the launch of community resilience programs throughout South Chicago Heights. Visit the Illinois Department of Human Services for further information on ongoing efforts to curtail drug abuse.

Local Drug Busts & News in South Chicago Heights, IL

Recent collaborations between South Chicago Heights law enforcement and federal agencies have led to significant drug busts in 2023. In a joint operation, authorities seized large quantities of fentanyl and methamphetamine, disrupting major distribution networks in Cook County. Continuous crackdowns are part of broader efforts to diminish illicit drug circulation in the region.

Moreover, community events and forums organized by local coalitions raise awareness about the adverse effects of drug abuse. These events aim to foster dialogue and offer support to those affected. Informed citizens and vigilant law enforcement play a pivotal role in safeguarding South Chicago Heights from escalating drug-related issues. Regular workshops and neighborhood watch programs are proving instrumental in maintaining community safety.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in South Chicago Heights, IL. Trusted by employers nationwide for accurate results and exceptional service.

Illinois DOT/Non DOT Physicals

Illinois Vision Tests

Illinois Audiograms

Illinois Respirator Fit Tests

Illinois Lift Tests

Illinois Background Checks

Clinical Testing Services

TB Testing in IL

Diabetes Testing in IL

Infectious Disease Testing in IL

Sickle Cell Anemia Testing in IL

Women/Men's Health Testing in IL

Resources & Citations

Illinois Department of Human Services

National Institute on Drug Abuse - Illinois

Illinois Prevention Resource Center

Recovery.org - Illinois Recovery Centers

Gateway Foundation

Rosecrance Health Network

Hazelden Betty Ford Foundation

Substance Abuse and Mental Health Services Administration (SAMHSA)

NAMI Illinois

Drug Testing Near South Chicago Heights, IL

Sunny Crest, IL

Glenwood, IL

Flossmoor, IL

Matteson, IL

Sauk Village, IL

University Park, IL

Richton Park, IL

Ford Heights, IL

Olympia Fields, IL

Crete, IL

Chicago Heights, IL

Steger, IL

Frequently Asked Questions

Customer Reviews